Jiménez MBB

Language: Spanish
References: 17
Page: 17-25
PDF size: 185.88 Kb.

ABSTRACT

A descriptive cross-sectional, observational study was made with 38 patients who were performing hemodialysis at “Arnaldo Milian Castro” University Provincial Hospital of Villa Clara Province, in the period between January 2014 and January 2015 those who performed bone densitometry. Chronic kidney disease predominated in patients included between 45 and 54 years old, white skin and male sex and hypertension was the disease most commonly associated. In bone densitometry values predominated moderate and severe osteopenia; patients who took steroid had more osteopenia and osteoporosis as well as those who practiced little physical activity; the values of calcium, phosphorus and albumin were not related to the results of bone densitometry; it was shown that with increasing time of hemodialysis the value of bone densitometry diminished and there is 80.4% of dependence on other variables not studied such as diet, the calcium value before and after hemodialysis and even proper genetics of the patient.

REFERENCES

1. Jamal SA, West SL, Miller PD. Fracture risk assessment in patients with chronic kidney disease. Osteoporos Int. 2012;23:1191.

2. Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006 Nov;17(11):3223-32. Epub 2006 Sep 27.

3. Ensrud KE, Lui LY, Taylor BC, Ishani A, Shlipak MG, Stone KL. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med. 2007 Jan 22;167(2):133-9.

4. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009 Aug;(113):S1-130. doi: 10.1038/ki.2009.188.

5. Bardin T, Richette P. Rheumatic manifestations of renal disease. Cur Opin Rheumatol. 2009;21:55-61.

6. Culak CA, Dempster D. Bone histomorphometry: a concise review for endocrinologists and clinicians. Arq Bras Endocrinol Metabol. 2010 Mar;54(2):87-98.

7. Ranch D, Zhang MY, Portale AA, Perwad F. Fibroblast growth factor-23 regulates renal 1,25(OH)(2) D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice. J Bone Miner Res. 2011 Aug;26(8):1883-90. doi: 10.1002/jbmr.401.

8. Kiattisunthorn K, Moe SM. Chronic kidney disease-mineral bone disorder (CKD-MBD). IBMS Bone-Key. 2010;12:447-57.

9. Jamal S, Ljunggren O, Stehman-Breen C, Cummings S, McClung M, Goemaere S. The effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res. 2011 Aug;26(8):1829-35. doi: 10.1002/jbmr.403.

10. 10.Miller PD. The kidney and bisphosphonates. Bone. 2011 Jul;49(1):77-81. doi: 10.1016/j.bone.2010.12.024.

11. 11.Jamal SA. Bone mass measurements in men and women with chronic kidney disease. Curr Opin Nephrol Hipertens. 2010;19(4):343-48.

12. 12.Orlic L, Crncevic Z, Pavlovic D, Zaputovic L. Bone mineral densitometry in patients on haemodialysis: difference between genders and what to measure. Ren Fail. 2010 Jan;32(3):300-8. doi: 10.3109/08860221003611661.

13. 13.Mezzano A, Sergio Aros E. Enfermedad renal crónica: clasificación, mecanismos de progresión y estrategias de renoprotección. Rev Méd Chile. 2005;133:338-48.

14. 14.Akizawa T, Fukagawa M, Koshikawa S, Kurokawa K. Recent progress in the management of secondary hyperparathyroidism of chronic renal failure. Curr Opin Nephrol Hypertens. 1993;2(4):558-65.

15. 15.Reyes L. Estimación de la masa ósea de pacientes en hemodiálisis por radiogrametría radiológica digital (DXR). Nefrología [Internet]. 2003 [citado 18 Dic 2014];XXIII(supl 2): [aprox. 5 p.]. Disponible en: http://www.revistanefrologia.com/es-publicacion-nefrologia-articulo-estimacio

16. 16.Tercer curso de acreditación en Técnicas de Medición ósea [Internet]. Barcelona: Sociedad Española de Investigaciones óseas y metabolismo mineral; 2004 [citado 18 Dic 2014]. Disponible en: http://www.fhoemo.com/wp-content/uploads/2014/06/III-Curso-de-Medici%C3%B3n-%C3%93sea-_Barcelona-2004.pdf

17. 17.Urena P, Bernard-Poenaru O, Osterlag A, Baudoin C, Cohen Solai M, Cantor T, et al. Bone mineral density biochemical markers and skeletal fractures in haemodialysis patients. Nephrol Dial Transplant. 2003;18(11):232-41.